| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |